Balaxi Ventures plans to enter the central American markets of El Salvador, Nicaragua, and Honduras by setting up wholly-owned distribution units, eyeing these smaller but high-margin pharmaceutical markets. The expansion in El Salvador, Nicaragua and Honduras follows the company's foray into landlocked Central African Republic last year. The pharmaceutical firm plans to start operations in all the three markets by the first quarter of next year.